SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-082324
Filing Date
2018-03-14
Accepted
2018-03-14 16:13:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d547636d424b5.htm 424B5 648932
2 GRAPHIC g547636g05m95.jpg GRAPHIC 45822
3 GRAPHIC g547636g55s82.jpg GRAPHIC 38397
  Complete submission text file 0001193125-18-082324.txt   765988
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-205513 | Film No.: 18689609
SIC: 2834 Pharmaceutical Preparations